ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
불면증 치료제 시장 규모는 향후 몇 년간 강한 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 AI 기반 수면 모니터링의 발전, 개인 맞춤형 의약품에 대한 수요 증가, 수면 장애를 가진 노인 인구 증가, 정신 건강에 대한 인식 제고, 새로운 불면증 의약품의 파이프라인 확대에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 불면증 치료에 디지털 치료법의 통합, 비약물적 치료법의 선호도 증가, 웨어러블 수면 추적기의 채택 증가, 차세대 수면 약물의 개발, 수면 장애 관리를 위한 원격 의료의 성장 등이 있습니다.
스트레스 수준이 높아지고 생활 방식이 변화함에 따라 불면증 치료제 시장이 성장할 것으로 예상됩니다. 이러한 요인들은 정서적 긴장과 수면 패턴의 혼란을 야기하는 일상 생활의 심리적, 행동적 변화를 의미합니다. 현대 생활에서 끊임없는 디지털 연결은 일과 삶의 경계를 무너뜨리고, 적절한 정신적 휴식 시간을 제한하며, 스트레스 수준을 악화시킵니다. 불면증 치료제는 건강한 수면 패턴을 회복하고, 수면 관련 불안을 완화하며, 현대 생활의 압박 속에서 정신 건강을 지원하는 효과적이고 과학적으로 입증된 치료 솔루션을 제공합니다. 예를 들어, 2024년 5월 미국 정신의학협회(APA)는 불안감을 느끼는 미국 성인의 비율이 2022년 32%에서 2024년 43%로 증가했다고 보고했습니다. 불안과 스트레스 수준이 높아짐에 따라 불면증 치료에 대한 수요가 증가하여 시장 확장이 더욱 촉진되고 있습니다.
불면증 치료제 시장의 선도 기업들은 듀얼 오렉신 수용체 억제제(DORAs)와 같은 고급 치료법 개발에 집중하고 있습니다. 이는 부작용이 적고 안전성이 향상된 맞춤형 치료 옵션을 제공하기 위함입니다. DORAs는 뇌의 오렉신-1과 오렉신-2 수용체를 차단하는 약물로, 이 수용체는 각성 촉진에 관여합니다. 이 수용체를 억제함으로써 DORAs는 수면을 유도하며, 특히 만성 불면증 치료에 효과적입니다. 2023년 6월, Idorsia Pharmaceuticals Ltd.는 만성 불면증 장애 치료를 위한 첫 번째 DORA인 QUVIVIQ(daridorexant)를 출시했습니다. 이 치료제는 자연스러운 수면 구조를 방해하지 않으면서 야간 각성을 감소시켜 환자의 수면 시작, 유지, 및 주간 기능 개선을 제공합니다. QUVIVIQ의 승인은 불면증 치료 분야에서 장기적이며 습관성 없는 치료 옵션의 필요성을 충족시키는 중요한 돌파구를 마련했습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 불면증 치료제 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 불면증 치료제 시장 : 성장률 분석
세계의 불면증 치료제 시장 실적: 규모와 성장(2019-2024년)
세계의 불면증 치료제 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 불면증 치료제 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 불면증 치료제 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
의약품
의료기기
세계의 불면증 치료제 시장 : 처방별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
정제
캡슐
액체 솔루션
패치
세계의 불면증 치료제 시장 : 투여 경로별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구
정맥내
경피
기타 투여 경로
세계의 불면증 치료제 시장 : 유통 채널별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 약국
소매 약국
온라인 약국
클리닉
웰니스 센터
세계의 불면증 치료제 시장 : 의약품 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 불면증 치료제 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 불면증 치료제 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
불면증 치료제 시장 : 경쟁 구도
불면증 치료제 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Sanofi SA : 개요, 제품 및 서비스, 전략 및 재무 분석
Takeda Pharmaceutical Company Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
Eli Lilly and Company : 개요, 제품 및 서비스, 전략 및 재무 분석
Merck KGaA : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Eisai Co. Ltd.
Sumitomo Pharma Co. Ltd.
Aurobindo Pharma
Astellas Pharma Inc.
Acadia Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc.
Idorsia Ltd
Minerva Neurosciences
Big Health
Neurovalens
Electromedical Products International Inc.
Neurim Pharmaceuticals Ltd.
Innovative Neurological Devices(IND)
Blake Insomnia Therapeutics Inc.
Cereve Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
불면증 치료제 시장(2029년) : 새로운 기회를 제공하는 국가
불면증 치료제 시장(2029년) : 새로운 기회를 제공하는 부문
불면증 치료제 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Insomnia therapeutics refer to treatments designed to manage and alleviate the symptoms of insomnia, a condition characterized by difficulty falling or staying asleep. These treatments include prescription medications, over-the-counter sleep aids, and non-pharmacological approaches such as cognitive behavioral therapy for insomnia (CBT-I).
The primary treatment types in insomnia therapeutics are drugs and medical devices. Drugs used in insomnia therapeutics are pharmacological agents specifically developed to treat sleep disorders by improving sleep initiation, maintenance, or overall sleep quality through mechanisms that regulate the sleep-wake cycle. These formulations include tablets, capsules, liquid solutions, and patches, and are administered through various routes such as oral, intravenous, transdermal, and others. They are distributed through multiple channels, including hospital pharmacies, retail pharmacies, online pharmacies, clinics, and wellness centers.
The insomnia therapeutics market research report is one of a series of new reports from The Business Research Company that provides insomnia therapeutics market statistics, including insomnia therapeutics industry global market size, regional shares, competitors with an insomnia therapeutics market share, detailed insomnia therapeutics market segments, market trends and opportunities, and any further data you may need to thrive in the insomnia therapeutics industry. This insomnia therapeutics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The insomnia therapeutics market size has grown strongly in recent years. It will grow from$3.03 billion in 2024 to $3.21 billion in 2025 at a compound annual growth rate (CAGR) of 6.0%. The growth during the historic period can be attributed to the increasing prevalence of insomnia, greater awareness of sleep disorders, the rising adoption of cognitive behavioral therapy for insomnia (CBT-I), the expansion of pharmaceutical treatments, and the growing use of over-the-counter sleep aids.
The insomnia therapeutics market size is expected to see strong growth in the next few years. It will grow to$4.01 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth during the forecast period can be attributed to advancements in AI-driven sleep monitoring, increasing demand for personalized medicine, a growing geriatric population with sleep disorders, rising mental health awareness, and an expanding pipeline of novel insomnia drugs. Key trends in the forecast period include the integration of digital therapeutics in insomnia treatment, the rising preference for non-pharmacological therapies, the increasing adoption of wearable sleep trackers, the development of next-generation sleep medications, and the growth of telemedicine for sleep disorder management.
The rising stress levels and lifestyle changes are expected to drive the growth of the insomnia therapeutics market. These factors refer to the psychological and behavioral shifts in daily routines that contribute to emotional strain and disrupted sleep patterns. The constant digital connectivity in modern life erodes work-life boundaries, limiting time for proper mental rest and exacerbating stress levels. Insomnia therapeutics offer effective, science-backed treatment solutions that help restore healthy sleep patterns, alleviate sleep-related anxiety, and support mental well-being amid the pressures of modern life. For example, in May 2024, the American Psychiatric Association (APA) reported that the percentage of U.S. adults feeling more anxious rose from 32% in 2022 to 43% in 2024. As anxiety and stress levels climb, the demand for insomnia treatments is growing, further driving the market's expansion.
Leading companies in the insomnia therapeutics market are focusing on developing advanced therapies, such as dual orexin receptor antagonists (DORAs), to offer targeted treatment options with fewer side effects and improved safety profiles. DORAs are medications that block both orexin-1 and orexin-2 receptors in the brain, which are involved in promoting wakefulness. By inhibiting these receptors, DORAs help induce sleep and are particularly effective in treating chronic insomnia. In June 2023, Idorsia Pharmaceuticals Ltd. launched QUVIVIQ (daridorexant), a first-in-class DORA for the treatment of chronic insomnia disorder. This therapy reduces nighttime wakefulness without disrupting natural sleep architecture, offering patients improved sleep onset, maintenance, and daytime functioning. QUVIVIQ's approval marks a significant breakthrough in insomnia treatment, addressing the need for long-term, non-habit-forming therapeutic options.
In August 2022, ResMed Inc. acquired Mementor, a company providing digital health solutions for sleep disorders such as insomnia. This acquisition strengthens ResMed's position in the insomnia therapeutics market by integrating Mementor's evidence-based digital health app into its offerings. With the integration, ResMed aims to expand access to reimbursable, digital therapy solutions in Germany, advancing its digital sleep medicine strategy. Mementor's app offers a digital approach to insomnia treatment, providing users with personalized, therapeutic content that addresses the root causes of sleep disturbances. This acquisition enhances ResMed's ability to offer accessible and innovative insomnia treatment solutions.
Major players in the insomnia therapeutics market are Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Eisai Co. Ltd., Sumitomo Pharma Co. Ltd., Aurobindo Pharma, Astellas Pharma Inc., Acadia Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Idorsia Ltd, Minerva Neurosciences, Big Health, Neurovalens, Electromedical Products International Inc., Neurim Pharmaceuticals Ltd., Innovative Neurological Devices (IND), Blake Insomnia Therapeutics Inc., and Cereve Inc.
North America was the largest region in the insomnia therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in insomnia therapeutics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the insomnia therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The insomnia therapeutics market consists of sales of herbal sleep aids, wearable sleep devices, sleep-enhancing audio devices, aromatherapy products, smart mattresses, sleep masks with embedded technology, blue light-blocking glasses, and biofeedback devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Insomnia Therapeutics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on insomnia therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for insomnia therapeutics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The insomnia therapeutics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Treatment Type: Drugs; Medical Devices
2) By Formulation: Tablets; Capsules; Liquid Solutions; Patches
3) By Route Of Administration: Oral; Intravenous; Transdermal; Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Clinics; Wellness Centers
Subsegments:
1) By Drugs: Benzodiazepines; Nonbenzodiazepines; Antidepressants; Orexin Antagonists; Melatonin Antagonists; Other Drugs
2) By Medical Devices: Cognitive Behavioral Therapy Devices (CBT-I Devices); Polysomnography Devices; Sleep Tracking Devices; Neurostimulation Devices; Light Therapy Devices
Companies Mentioned: Pfizer Inc.; Sanofi S.A.; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Merck KGaA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Insomnia Therapeutics Market Characteristics
3. Insomnia Therapeutics Market Trends And Strategies
4. Insomnia Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Insomnia Therapeutics Growth Analysis And Strategic Analysis Framework
5.1. Global Insomnia Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Insomnia Therapeutics Market Growth Rate Analysis
5.4. Global Insomnia Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Insomnia Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Insomnia Therapeutics Total Addressable Market (TAM)
6. Insomnia Therapeutics Market Segmentation
6.1. Global Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drugs
Medical Devices
6.2. Global Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Capsules
Liquid Solutions
Patches
6.3. Global Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Transdermal
Other Routes of Administration
6.4. Global Insomnia Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Clinics
Wellness Centers
6.5. Global Insomnia Therapeutics Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Benzodiazepines
Nonbenzodiazepines
Antidepressants
Orexin Antagonists
Melatonin Antagonists
Other Drugs
6.6. Global Insomnia Therapeutics Market, Sub-Segmentation Of Medical Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Insomnia Therapeutics Market
9.1. China Insomnia Therapeutics Market Overview
9.2. China Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Insomnia Therapeutics Market
10.1. India Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Insomnia Therapeutics Market
11.1. Japan Insomnia Therapeutics Market Overview
11.2. Japan Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Insomnia Therapeutics Market
12.1. Australia Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Insomnia Therapeutics Market
13.1. Indonesia Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Insomnia Therapeutics Market
14.1. South Korea Insomnia Therapeutics Market Overview
14.2. South Korea Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Insomnia Therapeutics Market
15.1. Western Europe Insomnia Therapeutics Market Overview
15.2. Western Europe Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Insomnia Therapeutics Market
16.1. UK Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Insomnia Therapeutics Market
17.1. Germany Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Insomnia Therapeutics Market
18.1. France Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Insomnia Therapeutics Market
19.1. Italy Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Insomnia Therapeutics Market
20.1. Spain Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Insomnia Therapeutics Market
21.1. Eastern Europe Insomnia Therapeutics Market Overview
21.2. Eastern Europe Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Insomnia Therapeutics Market
22.1. Russia Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Insomnia Therapeutics Market
23.1. North America Insomnia Therapeutics Market Overview
23.2. North America Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Insomnia Therapeutics Market
24.1. USA Insomnia Therapeutics Market Overview
24.2. USA Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Insomnia Therapeutics Market
26.1. South America Insomnia Therapeutics Market Overview
26.2. South America Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Insomnia Therapeutics Market
27.1. Brazil Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Insomnia Therapeutics Market
28.1. Middle East Insomnia Therapeutics Market Overview
28.2. Middle East Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Insomnia Therapeutics Market
29.1. Africa Insomnia Therapeutics Market Overview
29.2. Africa Insomnia Therapeutics Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Insomnia Therapeutics Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Insomnia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Insomnia Therapeutics Market Competitive Landscape And Company Profiles
